Raymond James Financial Inc. Invests $18.26 Million in BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Raymond James Financial Inc. purchased a new stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,072,040 shares of the company's stock, valued at approximately $18,257,000. Raymond James Financial Inc. owned 0.62% of BrightSpring Health Services as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. raised its position in BrightSpring Health Services by 2.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 450,993 shares of the company's stock valued at $7,680,000 after buying an additional 10,658 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in BrightSpring Health Services by 28.5% in the 4th quarter. Bank of New York Mellon Corp now owns 157,213 shares of the company's stock valued at $2,677,000 after acquiring an additional 34,907 shares in the last quarter. Rhumbline Advisers lifted its stake in BrightSpring Health Services by 1.5% in the 4th quarter. Rhumbline Advisers now owns 73,583 shares of the company's stock valued at $1,253,000 after acquiring an additional 1,118 shares in the last quarter. Legato Capital Management LLC lifted its stake in BrightSpring Health Services by 40.0% in the 4th quarter. Legato Capital Management LLC now owns 66,910 shares of the company's stock valued at $1,139,000 after acquiring an additional 19,120 shares in the last quarter. Finally, R Squared Ltd bought a new stake in BrightSpring Health Services in the 4th quarter valued at approximately $74,000.

Remove Ads

BrightSpring Health Services Stock Performance

NASDAQ:BTSG traded up $0.27 on Tuesday, hitting $17.72. The company's stock had a trading volume of 1,201,695 shares, compared to its average volume of 1,271,939. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The stock has a fifty day moving average of $20.04 and a two-hundred day moving average of $17.79. The firm has a market capitalization of $3.10 billion, a P/E ratio of -68.15 and a beta of 2.20. BrightSpring Health Services, Inc. has a one year low of $8.60 and a one year high of $24.82.

Analyst Ratings Changes

BTSG has been the topic of several research reports. Morgan Stanley boosted their target price on BrightSpring Health Services from $19.00 to $20.00 and gave the company an "overweight" rating in a research note on Tuesday, December 17th. Bank of America boosted their target price on BrightSpring Health Services from $19.00 to $21.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. CJS Securities began coverage on BrightSpring Health Services in a research note on Thursday, December 12th. They issued an "outperform" rating and a $27.00 price target for the company. UBS Group raised their price target on BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. Finally, Wells Fargo & Company raised their price target on BrightSpring Health Services from $17.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, November 27th. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $21.67.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.